Jennifer Wilbrink

Mrs. Jennifer Wilbrink


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2019 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
JWJennifer Wilbrink
Jennifer Wilbrink
NBNienke Bernards
Nienke Bernards
ZMZlatan Mujagic
Zlatan Mujagic
MAMark van Avesaat
Mark van Avesaat
KPKirsten Pijls
Kirsten Pijls
AMAd Masclee
Ad Masclee

27 December 2024 in Clinical Obesity
Verified
Journal Article
Open access
JWJennifer Wilbrink
Jennifer Wilbrink
MAMark van Avesaat
Mark van Avesaat
SNSimon W. Nienhuijs
Simon W. Nienhuijs
ASArnold Stronkhorst
Arnold Stronkhorst
AMAd A. M. Masclee
Ad A. M. Masclee
Summary: Background: Bariatric surgery is very effective in long‐term weight management. The present study was undertaken to investigate the short‐term effects of sleeve gastrectomy (SG) and of Roux‐en‐Y gastric bypass (RYGB) on (a) gastrointestinal (GI) motility, that is gastric emptying and oro‐cecal transit time and (b) secretion of regulatory gut peptides and (c) their interrelationship.Methods: Prospective single‐centre study in which we assessed gastric emptying, oro‐cecal transit time and gut peptide release in 28 severely obese individuals before and 2, respectively, 12 months after bariatric surgery (either SG or RYGB). Plasma PYY, GLP‐1, ghrelin, insulin and glucose levels were measured fasting and after intake of a solid standard 459 kcal meal at each occasion. Gastric emptying was measured by 13 C octanoic acid breath testing, and oro‐cecal transit time was measured by lactulose H2 breath testing. Satiation was measured using VAS scores.Results: After both RYGB and SG gastric emptying become significantly accelerated, and postprandial release of the distal gut peptides GLP‐1 and PYY becomes significantly increased, pointing to ileal brake activation. Oro‐cecal transit time becomes significantly accelerated after SG but not after RYGB. No significant correlations were observed between changes in distal gut peptide release, changes in GI motility and clinical parameters.Conclusion: Both SG and RYGB resulted in significant weight loss and significantly affected GI motility and PYY and GLP‐1 secretion. Subtle differences between both procedures were found in effect on oro‐cecal transit time and patterns of peptide secretion.

20 September 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
DTDanyta I. Tedjo
Danyta I. Tedjo
JWJennifer Wilbrink
Jennifer Wilbrink
JBJos Boekhorst
Jos Boekhorst
HTHarro M. Timmerman
Harro M. Timmerman
SNSimon W. Nienhuijs
Simon W. Nienhuijs
DJDaisy M. A. E. Jonkers
Daisy M. A. E. Jonkers
Background: The intestinal microbiota plays an important role in the etiology of obesity. Sleeve gastrectomy (SG) is a frequently performed and effective therapy for morbid obesity. Objective: To investigate the effect of sleeve gastrectomy on the fecal microbiota of individuals with morbid obesity and to examine whether shifts in microbiota composition are associated with markers of inflammation and intestinal barrier function. Methods: Fecal and blood samples of healthy individuals (n = 27) and morbidly obese individuals pre-SG (n = 24), and at 2 months (n = 13) and 6 months post-SG (n = 9) were collected. The 16SrRNA gene was sequenced to assess microbiota composition. Fecal calprotectin, plasma inflammatory markers and intestinal permeability markers (multi-sugar test) were determined. Results: Fecal microbiota composition between morbidly obese and lean individuals was significantly different. The fecal microbiota composition changed significantly 2 and 6 months post-SG (p = 0.008) compared to pre-SG but not towards a more lean profile. The post-SG microbiota profile was characterized by an increase in facultative anaerobic bacteria, characteristic for the upper gastrointestinal tract. No correlations were found between inflammatory markers, intestinal permeability and microbial profile changes. Conclusions: Fecal microbiota composition in morbidly obese individuals changed significantly following SG. This change might be explained by functional changes induced by the SG procedure.

30 December 2024 in Gastrointestinal Disorders
Verified
Journal Article
Open access
PDF file
JWJennifer Wilbrink
Jennifer Wilbrink
MAMark van Avesaat
Mark van Avesaat
ASArnold Stronkhorst
Arnold Stronkhorst
FTFreddy Troost
Freddy Troost
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux
AMA.A.M. Masclee
A.A.M. Masclee
Objective: The regulation of food intake is disturbed in obesity, possibly resulting from alterations in gut peptide secretion. We hypothesize that obesity is associated with attenuated systemic and tissue concentrations of the gut peptides PYY and GLP-1. Methods: A prospective single-center study in which we included 13 individuals with obesity (BMI 39.5 ± 2.8 kg/m2) and 11 lean individuals as controls (BMI 20.7 ± 1.2 kg/m2) matched for age and gender. We measured: (1) tissue concentrations and mRNA expression of GLP-1 and PYY in ileal and colonic biopsies taken during routine colonoscopy and (2) plasma concentrations of PYY and GLP-1 in response to a meal in the same group. Results: Plasma GLP-1 and PYY responses did not differ between individuals with obesity and lean controls. Neither were tissue concentrations and mRNA expression of both peptides different between both groups. Conclusions: Systemic and local PYY and GLP-1 concentrations in individuals with obesity do not differ from those in lean subjects.